Company profile

Santhera Pharmaceuticals Ltd.

We are a global specialty pharmaceutical company based in Switzerland committed to development and commercialization of innovative medicines to meet the needs of patients living with rare diseases.

More news about Santhera Pharmaceuticals Ltd.

02.04.2024 15:00

A positive growth trajectory for three pharmaceutical startups

Please login or
register to use the
awards follow feature
13.10.2023 10:00

EU approval for Santhera's vamorolone in sight

Please login or
register to use the
awards follow feature
07.08.2023 11:20

Chiesi Group acquires Santhera’s idebenone assets

Please login or
register to use the
awards follow feature
20.06.2023 16:40

Fresh money for Santhera and Idorsia

Please login or
register to use the
awards follow feature
16.01.2023 10:40

Listed Swiss Biotechs at full throttle

Please login or
register to use the
awards follow feature
04.01.2022 15:30

Santhera inks exclusive agreement with USD 20M upfront payment

Please login or
register to use the
awards follow feature
20.09.2021 09:51

Santhera Secures CHF 45 Million

Please login or
register to use the
awards follow feature
09.09.2015 12:37

Market approval for Santhera’s Raxone

Please login or
register to use the
awards follow feature
07.08.2015 10:12

Santhera raises CHF 27.7 million in new capital

Please login or
register to use the
awards follow feature
17.04.2015 11:52

Nine hot start-ups, 400 visitors and Joe Jimenez

Please login or
register to use the
awards follow feature
Santhera Pharmaceuticals Ltd.

Founded
2002

Kanton
Basel-Landschaft


LinkedIn

Twitter
@santhera

Homepage

rss